Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis

Aurelie Hanin*, Anthony D. Jimenez, Margaret Gopaul, Hannah Asbell, Seyhmus Aydemir, Maysaa Merhi Basha, Ayush Batra, Charlotte Damien, Gregory S. Day, Onome Eka, Krista Eschbach, Safoora Fatima, Madeline C. Fields, Brandon Foreman, Elizabeth E. Gerard, Teneille E. Gofton, Hiba A. Haider, Stephen T. Hantus, Sara Hocker, Amy JongelingMariel Kalkach Aparicio, Padmaja Kandula, Peter Kang, Karnig Kazazian, Marissa A. Kellogg, Minjee Kim, Jong Woo Lee, Lara V. Marcuse, Christopher M. McGraw, Wazim Mohamed, Janet Orozco, Cederic M. Pimentel, Vineet Punia, Alexandra M. Ramirez, Claude Steriade, Aaron F. Struck, Olga Taraschenko, Andrew K. Treister, Mark Wainwright, Ji Yeoun Yoo, Sahar Zafar, Daniel J. Zhou, Deepti Zutshi, Nicolas Gaspard, Lawrence J. Hirsch

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Trends in management of patients with new-onset refractory status epilepticus (NORSE) from 2016 to 2023: An interim analysis'. Together they form a unique fingerprint.

Keyphrases

Neuroscience

Immunology and Microbiology